ラボオンチップの世界市場

ラボオンチップの世界市場は2030年までに米国で142億米ドルに達する見込み

2024年に83億米ドルと推定されるラボオンチップの世界市場は、2024年から2030年にかけてCAGR 9.4％で成長し、2030年には142億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器は、CAGR 10.0％を記録し、分析期間終了までに80億米ドルに達すると予測されます。試薬・消耗品セグメントの成長率は、分析期間中CAGR 9.3％と推定されます。

米国市場は23億米ドルと推定・予測、中国はCAGR 8.8％で成長予測

米国のラボオンチップ市場は、2024年に23億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.8%で推移し、2030年には22億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.8％と7.5％と予測されています。欧州では、ドイツがCAGR約7.5%で成長すると予測されています。

世界のラボオンチップ市場- 主要動向と促進要因のまとめ

ラボオンチップはどのように診断に革命をもたらすか？

ラボオンチップ（LOC）技術は、複雑な検査プロセスをコンパクトなマイクロ流体チップ上で実行できるようにすることで、診断学に変革をもたらします。これらのデバイスは、サンプル調製、検出、データ解析などの複数の検査機能を1つのチップに統合し、迅速、正確、かつコスト効果の高い診断ソリューションを提供します。LOCシステムは、救急外来や遠隔地の医療現場など、迅速な結果がタイムリーな意思決定に不可欠なポイントオブケア（POC）診断において特に有用です。バイオマーカー、病原体、遺伝子変異を迅速に検出できるラボオンチップデバイスは、中央研究所ではなく、必要な時点で実施できる、より効率的で利用しやすいヘルスケア診断へのシフトを推進しています。

なぜ個別化医療とゲノミクスがラボオンチップの需要を牽引しているのか？

個別化医療とゲノミクスの台頭は、正確で患者に特化した診断に理想的なラボオンチップデバイスの需要を大幅に押し上げています。個別化医療は、個々の遺伝子プロファイルに基づいた治療のカスタマイズに重点を置いており、遺伝子情報の迅速で信頼性の高い分析が必要とされています。ラボオンチップテクノロジーは、PCRやDNAシーケンスのような複雑なゲノム解析の小型化と自動化を可能にし、従来の方法と比較して必要な時間とリソースを削減します。腫瘍学や希少疾患管理などの分野で個別化医療が普及するにつれて、LOCデバイスはターゲットを絞ったヘルスケアソリューションを提供するための不可欠なツールになりつつあり、患者レベルでの高度な診断がより現実的になっています。

小型化と可搬性は研究と診断にどのような影響を与えているか？

小型化と可搬性は、調査ラボ、フィールド診断、資源が限られた環境での普及を可能にする、ラボオンチップ技術の中心的な利点です。LOCデバイスのコンパクトなサイズは、分子生物学的実験から病原体の検出まで、高度な検査機能のポータビリティを可能にし、ラボのインフラが完備されていない場所での診断を容易にします。これらの装置は、最小限のサンプル量と試薬量で分析を行うことができ、コストと廃棄物を削減することができるため、遠隔地や低資源環境では特に有益です。さらに、マイクロ流体システムとセンサーをデジタル接続で統合することで、リアルタイムのデータ転送が可能になり、遠隔モニタリングやクラウドベースのデータ解析が可能になり、診断や研究の洞察が強化されます。

ラボオンチップ市場の成長の原動力は？

ラボオンチップ市場の成長は、迅速な診断の需要、個別化医療の進歩、ポータブルで小型化されたラボシステムのニーズの高まりなど、いくつかの要因によってもたらされます。ヘルスケア、特にポイントオブケアや救急医療における迅速で正確な診断へのニーズが、LOC技術の採用を後押ししています。正確な遺伝子・分子解析を必要とする個別化医療へのシフトも、特に腫瘍学や遺伝子検査などの分野でLOCの利用を加速させています。さらに、可搬性と最小限のリソース要件という利点により、LOCシステムは遠隔地やリソースの限られた環境に理想的であり、その市場範囲は拡大しています。これらの要因が総合的に、効率性と精度で現代のヘルスケアと研究のニーズに対応するラボオンチップ市場の拡大を支えています。

セグメント

アプリケーション（ゲノム＆プロテオミクス、診断、創薬、その他アプリケーション）、セグメント（装置、試薬＆消耗品、ソフトウェア＆サービス）

調査対象企業の例

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Fluidigm Corporation
• IDEX Corporation
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• その他の地域

第4章 競合

Global Lab-on-a-Chip Market to Reach US$14.2 Billion by 2030

The global market for Lab-on-a-Chip estimated at US$8.3 Billion in the year 2024, is expected to reach US$14.2 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.0 Billion by the end of the analysis period. Growth in the Reagents & Consumables segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.8% CAGR

The Lab-on-a-Chip market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Lab-on-a-Chip Market - Key Trends & Drivers Summarized

How Is Lab-on-a-Chip Revolutionizing Diagnostics?

Lab-on-a-chip (LOC) technology is transforming diagnostics by enabling complex laboratory processes to be performed on a compact, microfluidic chip. These devices integrate multiple laboratory functions, such as sample preparation, detection, and data analysis, onto a single chip, offering fast, accurate, and cost-effective diagnostic solutions. LOC systems are particularly valuable in point-of-care (POC) diagnostics, where rapid results are essential for timely decision-making, such as in emergency rooms or remote healthcare settings. With the ability to detect biomarkers, pathogens, and genetic mutations quickly, lab-on-a-chip devices are driving a shift toward more efficient, accessible healthcare diagnostics that can be administered at the point of need rather than in centralized laboratories.

Why Are Personalized Medicine and Genomics Driving Demand for Lab-on-a-Chip?

The rise of personalized medicine and genomics is significantly boosting the demand for lab-on-a-chip devices, which are ideal for precise, patient-specific diagnostics. Personalized medicine focuses on tailoring treatments based on individual genetic profiles, requiring rapid and reliable analysis of genetic information. Lab-on-a-chip technology allows for the miniaturization and automation of complex genomic analyses, such as PCR and DNA sequencing, reducing time and resource requirements compared to traditional methods. As personalized medicine gains traction in fields like oncology and rare disease management, LOC devices are becoming essential tools for delivering targeted healthcare solutions, making advanced diagnostics more feasible at the patient level.

How Is Miniaturization and Portability Impacting Research and Diagnostics?

Miniaturization and portability are central advantages of lab-on-a-chip technology, enabling its widespread adoption in research labs, field diagnostics, and resource-limited settings. The compact size of LOC devices allows for the portability of sophisticated testing capabilities, from molecular biology experiments to pathogen detection, facilitating diagnostics in locations without full laboratory infrastructure. These devices can perform analyses with minimal sample and reagent volumes, reducing costs and waste, which is particularly beneficial in remote and low-resource settings. Additionally, the integration of microfluidic systems and sensors with digital connectivity allows real-time data transfer, enabling remote monitoring and cloud-based data analysis for enhanced diagnostics and research insights.

What Drives the Growth of the Lab-on-a-Chip Market?

The growth in the lab-on-a-chip market is driven by several factors, including the demand for rapid diagnostics, advancements in personalized medicine, and the increasing need for portable, miniaturized lab systems. The need for fast and accurate diagnostics in healthcare, especially in point-of-care and emergency settings, is propelling the adoption of LOC technology. The shift toward personalized medicine, which requires precise genetic and molecular analysis, is also accelerating LOC usage, especially in fields like oncology and genetic testing. Furthermore, the advantages of portability and minimal resource requirements make LOC systems ideal for remote and resource-limited settings, expanding their market reach. These factors collectively support the lab-on-a-chip market’s expansion as it addresses modern healthcare and research needs with efficiency and precision.

SCOPE OF STUDY:

The report analyzes the Lab-on-a-Chip market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Genomics & Proteomics, Diagnostics, Drug Discovery, Other Applications); Segment (Instruments, Reagents & Consumables, Software & Services)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 16 Featured) -

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Fluidigm Corporation
• IDEX Corporation
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Tariff Impact on Global Supply Chain Patterns
  • Lab-on-a-Chip - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Miniaturized Diagnostics and Point-of-Care Testing
  • Growth in Personalized Medicine Driving Demand for Lab-on-a-Chip Solutions
  • Advancements in Microfluidics Technology Enhancing Chip Capabilities
  • Expansion of Applications in Genomics and Proteomics Research
  • Rising Use of Lab-on-a-Chip Devices in Infectious Disease Diagnosis
  • Increased Adoption in Drug Discovery and Development Processes
  • Growing Demand for Cost-Effective and Rapid Diagnostic Solutions
  • Development of Multi-Analyte Detection Chips for Comprehensive Testing
  • Higher Investment in Lab-on-a-Chip R&D by Pharmaceutical Companies
  • Growth of Wearable and Implantable Lab-on-a-Chip Devices for Monitoring
  • Expansion of Lab-on-a-Chip in Food Safety and Environmental Testing
  • Integration of AI and Big Data in Lab-on-a-Chip for Enhanced Analytics
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Lab-on-a-Chip Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Genomics & Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Genomics & Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 18: USA Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 19: USA 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 20: USA Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 21: USA 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• CANADA
  • TABLE 22: Canada Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 23: Canada 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 24: Canada Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 25: Canada 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• JAPAN
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 26: Japan Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Japan 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 28: Japan Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 29: Japan 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• CHINA
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 30: China Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 31: China 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 32: China Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: China 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• EUROPE
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 34: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 35: Europe 6-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 36: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 37: Europe 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Europe 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• FRANCE
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 40: France Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 41: France 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 42: France Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 43: France 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• GERMANY
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 44: Germany Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Germany 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 46: Germany Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Germany 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• ITALY
  • TABLE 48: Italy Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 49: Italy 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 50: Italy Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Italy 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• UNITED KINGDOM
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 52: UK Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 53: UK 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 54: UK Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 55: UK 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Rest of Europe 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Rest of Europe 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• ASIA-PACIFIC
  • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Asia-Pacific 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Asia-Pacific 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 65: Rest of World 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
  • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 67: Rest of World 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030

IV. COMPETITION